Hambrecht & Quist Capital Management »

Codexis shares owned by Hambrecht & Quist Capital Management

Quarter-by-quarter ownership of Codexis (CDXS) shares owned by Hambrecht & Quist Capital Management from 13F filings

Historical chart of Hambrecht & Quist Capital Management investment in Codexis

Tip: Access up to 7 years of quarterly data

All positions including Codexis held by Hambrecht & Quist Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Codexis by Hambrecht & Quist Capital Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $194k 69k 2.80
2023-03-31 $286k 69k 4.14
2022-12-31 $322k 69k 4.66
2022-09-30 $419k 69k 6.06
2021-09-30 $1.9M 80k 23.26

More positions owned by Hambrecht & Quist Capital Management

Amgen Common (AMGN)
Johnson & Johnson Common (JNJ)
Gilead Sciences Common (GILD)
Regeneron Pharmaceuticals Common (REGN)
Vertex Pharmaceuticals Common (VRTX)
Eli Lilly and Company Common (LLY)
Unitedhealth Group Common (UNH)
Merck & Co Common (MRK)
AbbVie Common (ABBV)
Biogen Common (BIIB)
AstraZeneca Sponsored ADR (AZN)
Illumina Common (ILMN)
Abbott Laboratories Common (ABT)
Pfizer Common (PFE)
Thermo Fisher Scientific Common (TMO)

View all positions for Hambrecht & Quist Capital Management

Top funds holding Codexis

Nantahala Capital Management
Vanguard Group
Baillie Gifford & Co
Opaleye Management
Telemark Asset Management
Casdin Capital
Assenagon Asset Management
Jacobs Levy Equity Management
Federated Investors
Two Sigma Advisers
D. E. Shaw & Co
Millennium Management
Two Sigma Investments
Prescott Group Capital Management
Fred Alger Management

View all funds holding Codexis